MedPath

NORTHERN ARIZONA UNIVERSITY

NORTHERN ARIZONA UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1899-09-11
Employees
251
Market Cap
-
Website
http://www.nau.edu

Advancements in CGB-500 for Atopic Dermatitis Treatment

CAGE Bio Inc. is making strides in dermatological drug development with its ionic liquid formulation, CGB-500, showing promising results in clinical trials for atopic dermatitis. The company's CEO, Nitin Joshi, PhD, shared insights into the development process and the potential of this innovative treatment approach.
© Copyright 2025. All Rights Reserved by MedPath